Evidence map›Paper›PMID 33373523›Full record

ReviewChemical reviews2021

β-Lactams against the Fortress of the Gram-Positive

Jed F Fisher, Shahriar Mobashery

Open access · greenAbstract readReview
In one paragraph

Review in Chemical reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Secondary Resistome of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Two codependent routes lead to high-level MRSA.Science (New York, N.Y.) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. α-Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping.Angewandte Chemie (International ed. in English) · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Microbiology spectrum · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jed F FisherDepartment of Chemistry and Biochemistry, McCourtney Hall, University of Notre Dame, Notre Dame Indiana 46556, United States.ORCID 0000-0002-7174-4352
Shahriar MobasheryDepartment of Chemistry and Biochemistry, McCourtney Hall, University of Notre Dame, Notre Dame Indiana 46556, United States.ORCID 0000-0002-7695-7883
University of Notre Dame · US

Funding

Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus AureusR01AI104987 · NIAID · UNIVERSITY OF NOTRE DAME · PI Shahriar Mobashery · 2013 to 2026
$7.3M
NIAID NIH HHS R01 AI104987
6 · The paper itself

Abstract

The biological diversity of the unicellular bacteria-whether assessed by shape, food, metabolism, or ecological niche-surely rivals (if not exceeds) that of the multicellular eukaryotes. The relationship between bacteria whose ecological niche is the eukaryote, and the eukaryote, is often symbiosis or stasis. Some bacteria, however, seek advantage in this relationship. One of the most successful-to the disadvantage of the eukaryote-is the small (less than 1 μm diameter) and nearly spherical

Indexed as

AnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactam Resistancebeta-LactamsBiocatalysisCell WallCephalosporinsDrug DiscoveryEnzyme InhibitorsHumansPenicillin-Binding ProteinsPenicillinsProtein BindingProtein ConformationStaphylococcus aureusAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsCephalosporinsEnzyme InhibitorsPenicillin-Binding ProteinsPenicillins

Identifiers

PMID33373523
PMCPMC8653850
OpenAlexW3116311523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.